NCT05397600 · Interventional trial
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients
Overall registry status Completed
Phase 3
Conditions Glaucoma, Ocular Hypertension
Delaware Valley sites
- Scheie Eye Institute - University of Pennsylvania · Philadelphia, PA · Philadelphia County
- Wills Eye Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory